What is Outlook Therapeutics, Inc. Common Stock's Market Cap?

Outlook Therapeutics, Inc. Common Stock's Market Cap is $155.9M, based on as-reported figures from SEC (XBRL) filings.

What is Outlook Therapeutics, Inc. Common Stock's Enterprise Value?

Outlook Therapeutics, Inc. Common Stock's Enterprise Value is $174.1M, based on as-reported figures from SEC (XBRL) filings.

What is Outlook Therapeutics, Inc. Common Stock's Price / Sales?

Outlook Therapeutics, Inc. Common Stock's Price / Sales is 110.3×, based on as-reported figures from SEC (XBRL) filings.

What is Outlook Therapeutics, Inc. Common Stock's EV / Revenue?

Outlook Therapeutics, Inc. Common Stock's EV / Revenue is 123.2×, based on as-reported figures from SEC (XBRL) filings.

What is Outlook Therapeutics, Inc. Common Stock's EV / EBITDA?

Outlook Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Outlook Therapeutics, Inc. Common Stock's Revenue (TTM)?

Outlook Therapeutics, Inc. Common Stock's Revenue (TTM) is $1.4M, based on as-reported figures from SEC (XBRL) filings.

What is Outlook Therapeutics, Inc. Common Stock's Net Income (TTM)?

Outlook Therapeutics, Inc. Common Stock's Net Income (TTM) is -$61.1M, based on as-reported figures from SEC (XBRL) filings.

What is Outlook Therapeutics, Inc. Common Stock's EBITDA?

Outlook Therapeutics, Inc. Common Stock's EBITDA is -$55.5M, based on as-reported figures from SEC (XBRL) filings.

What is Outlook Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Outlook Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.25, based on as-reported figures from SEC (XBRL) filings.

What is Outlook Therapeutics, Inc. Common Stock's EBITDA Margin?

Outlook Therapeutics, Inc. Common Stock's EBITDA Margin is -3928.6%, based on as-reported figures from SEC (XBRL) filings.

Outlook Therapeutics, Inc. Common Stock (OTLK) Financial Statements

Outlook Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00469JRM1

XNAS · usd

0.64▼ 0.03 (-3.90%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close0.67

Day's Range0.63 – 0.67

52-Week Range0.16 – 2.54

Volume4.8M

Avg Volume18.9M

Share Statistics

Shares Outstanding

Employees17

ExchangeXNAS

Listed2016-05-13

Share count as of August 14, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Outlook Therapeutics, Inc. Common Stock (OTLK)

What is Outlook Therapeutics, Inc. Common Stock's Market Cap?: Outlook Therapeutics, Inc. Common Stock's Market Cap is $155.9M, based on as-reported figures from SEC (XBRL) filings.
What is Outlook Therapeutics, Inc. Common Stock's Enterprise Value?: Outlook Therapeutics, Inc. Common Stock's Enterprise Value is $174.1M, based on as-reported figures from SEC (XBRL) filings.
What is Outlook Therapeutics, Inc. Common Stock's Price / Sales?: Outlook Therapeutics, Inc. Common Stock's Price / Sales is 110.3×, based on as-reported figures from SEC (XBRL) filings.
What is Outlook Therapeutics, Inc. Common Stock's EV / Revenue?: Outlook Therapeutics, Inc. Common Stock's EV / Revenue is 123.2×, based on as-reported figures from SEC (XBRL) filings.
What is Outlook Therapeutics, Inc. Common Stock's EV / EBITDA?: Outlook Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Outlook Therapeutics, Inc. Common Stock's Revenue (TTM)?: Outlook Therapeutics, Inc. Common Stock's Revenue (TTM) is $1.4M, based on as-reported figures from SEC (XBRL) filings.
What is Outlook Therapeutics, Inc. Common Stock's Net Income (TTM)?: Outlook Therapeutics, Inc. Common Stock's Net Income (TTM) is -$61.1M, based on as-reported figures from SEC (XBRL) filings.
What is Outlook Therapeutics, Inc. Common Stock's EBITDA?: Outlook Therapeutics, Inc. Common Stock's EBITDA is -$55.5M, based on as-reported figures from SEC (XBRL) filings.
What is Outlook Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Outlook Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.25, based on as-reported figures from SEC (XBRL) filings.
What is Outlook Therapeutics, Inc. Common Stock's EBITDA Margin?: Outlook Therapeutics, Inc. Common Stock's EBITDA Margin is -3928.6%, based on as-reported figures from SEC (XBRL) filings.